Compare
Nutex Health Inc. vs Claritev Corp vs Payoneer Global Inc. vs Xometry, Inc.
| Latest fiscal year | Nutex Health Inc. NUTX | Claritev Corp CTEV | Payoneer Global Inc. PAYO | Xometry, Inc. XMTR |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $875.26M | $965.41M | $1.05B | $686.63M |
| Revenue growth (YoY) | +82.4% | +3.7% | +7.7% | +25.9% |
| Gross margin | 50.8% | n/a | n/a | 39.1% |
| Operating margin | 31.5% | 3.0% | 11.8% | -6.6% |
| Net margin | 8.1% | -29.4% | 7.0% | -9.0% |
| Net income | $70.79M | -$284.28M | $73.19M | -$61.75M |
| EPS (Diluted) | $10.48 | -$17.30 | $0.19 | n/a |
| Operating cash flow | $248.12M | $117.32M | $233.49M | $6.09M |
| Free cash flow | $245.60M | -$12.28M | $206.62M | -$24.09M |
| Cash & equivalents | $185.57M | $16.81M | $415.54M | $15.00M |
| Total assets | $918.52M | $4.89B | $8.96B | $703.72M |
| Total liabilities | $495.09M | $5.06B | $8.25B | $426.98M |
| Shareholders' equity | $423.44M | -$173.90M | $704.43M | $276.74M |
| Return on year-end equity | 16.7% | n/a | 10.4% | -22.3% |
| Shares outstanding | 7.09M | 16.55M | 348.70M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Nutex Health Inc. | Claritev Corp | Payoneer Global Inc. | Xometry, Inc. |
|---|---|---|---|---|
| Latest | $875.26M Ended 2025-12-31 | $965.41M Ended 2025-12-31 | $1.05B Ended 2025-12-31 | $686.63M Ended 2025-12-31 |
| 1 year earlier | $479.95M Ended 2024-12-31 | $930.62M Ended 2024-12-31 | $977.72M Ended 2024-12-31 | $545.53M Ended 2024-12-31 |
| 2 years earlier | $247.65M Ended 2023-12-31 | $961.52M Ended 2023-12-31 | $831.10M Ended 2023-12-31 | $463.41M Ended 2023-12-31 |
| 3 years earlier | $219.29M Ended 2022-12-31 | $1.08B Ended 2022-12-31 | $627.62M Ended 2022-12-31 | $380.92M Ended 2022-12-31 |
| 4 years earlier | $331.53M Ended 2021-12-31 | $1.12B Ended 2021-12-31 | $473.40M Ended 2021-12-31 | $218.34M Ended 2021-12-31 |